Safety, tolerability, and risks associated with first-and second-generation antipsychotics: a state-of-the-art clinical review

M Solmi, A Murru, I Pacchiarotti… - … and clinical risk …, 2017 - Taylor & Francis
Since the discovery of chlorpromazine (CPZ) in 1952, first-generation antipsychotics (FGAs)
have revolutionized psychiatric care in terms of facilitating discharge from hospital and …

Repurposing psychiatric drugs as anti-cancer agents

J Huang, D Zhao, Z Liu, F Liu - Cancer letters, 2018 - Elsevier
Cancer is a major public health problem and one of the leading contributors to the global
disease burden. The high cost of development of new drugs and the increasingly severe …

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

CU Correll, J Detraux, J De Lepeleire… - World …, 2015 - Wiley Online Library
People with severe mental illness have a considerably shorter lifespan than the general
population. This excess mortality is mainly due to physical illness. Next to mental illness …

Synergistic growth inhibition of HT-29 colon and MCF-7 breast cancer cells with simultaneous and sequential combinations of antineoplastics and CNS drugs

D Duarte, A Cardoso, N Vale - International Journal of Molecular Sciences, 2021 - mdpi.com
Several central nervous system (CNS) drugs exhibit potent anti-cancer activities. This study
aimed to design a novel model of combination that combines different CNS agents and …

Association of schizophrenia with the risk of breast cancer incidence: a meta-analysis

C Zhuo, PT Triplett - JAMA psychiatry, 2018 - jamanetwork.com
Importance Patients with schizophrenia are considered to have many risk factors for the
development of cancer. However, the incidence of breast cancer in women with …

Cancer incidence and stage at diagnosis among people with psychotic disorders: Systematic review and meta-analysis

JC Wootten, JC Wiener, PS Blanchette… - Cancer Epidemiology, 2022 - Elsevier
Research regarding the incidence of cancer among people with psychotic disorders relative
to the general population is equivocal, although the evidence suggests that they have more …

Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy

V Shaw, S Srivastava, SK Srivastava - Seminars in cancer biology, 2021 - Elsevier
The recent development of high throughput compound screening has allowed drug
repurposing to emerge as an effective avenue for discovering novel treatments for cancer …

Antidepressant drug sertraline against human cancer cells

D Duarte, N Vale - Biomolecules, 2022 - mdpi.com
The use of FDA-approved drugs for new indications represents a faster and more
economical way to find novel therapeutic agents for cancer therapy, compared to the …

The incidence rate of cancer in patients with schizophrenia: a meta-analysis of cohort studies

H Li, J Li, X Yu, H Zheng, X Sun, Y Lu, Y Zhang… - Schizophrenia …, 2018 - Elsevier
Background Numerous studies report that cancer prevalence in patients with schizophrenia
might be different from the general population, but findings remain controversial. Aim Our …

Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review

M De Hert, J Peuskens, T Sabbe… - Acta Psychiatrica …, 2016 - Wiley Online Library
Objective A recent meta‐analysis showed that breast cancer probably is more common in
female patients with schizophrenia than in the general population (effect size= 1.25, P< …